AYCARDI-FONSECA ERNESTO 4
4 · Xenon Pharmaceuticals Inc. · Filed Mar 20, 2018
Insider Transaction Report
Form 4
AYCARDI-FONSECA ERNESTO
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2018-03-19+50,000→ 50,000 totalExercise: $4.65Exp: 2028-03-18→ Common Shares (50,000 underlying)
Footnotes (1)
- [F1]Vesting 25% on March 19, 2019, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month.